EXEL EXELIXIS, INC.

NEUTRAL Impact: 3/10 8-K
Horizon days Filed May 29, 2026 Processed 11d 11h ago SEC 0000939767-26-000074
8-K context-dependent: Items 5.02
Latest settled — T+5d ⚠ clustered
EXEL ▲ +4.98% at T+5d
NEUTRAL call ✓ call won +4.98% · α vs SPY +7.73% · entry $50.20 → $52.70
Next anchor: T+20d in 19d
Last close $51.74 (close Jun 8) · +3.07% from $50.20 entry
Entry anchored
May 29, 2026
via day open
T+1d
-3.41%
call -3.41% · α -3.55%
$48.49
settled 9d ago
T+5d
+4.98%
call +4.98% · α +7.73%
$52.70
settled 5d ago
T+20d
call — · α —
in 19d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

Exelixis held its 2026 Annual Meeting on May 26, 2026, where stockholders approved the amendment and restatement of the 2017 Equity Incentive Plan, adding 2,000,000 new shares to the share reserve, and ratified the selection of Ernst & Young as independent auditor. All 11 director nominees were elected, and the advisory Say on Pay proposal passed. This is a routine governance filing with no material financial impact.

Actionable Insight

Routine annual meeting results with no surprises. The 2M share increase to the equity plan is small relative to market cap and standard for ongoing compensation. No trading catalyst here — monitor next quarterly earnings for fundamental performance.

Key Facts

  • Stockholders approved the amendment and restatement of the 2017 Equity Incentive Plan, adding 2,000,000 new shares to the share reserve (total share reserve now 75,953,064 shares).
  • All 11 director nominees were elected with strong support (lowest 'for' vote was 180,367,648 for Maria C. Freire).
  • Ratification of Ernst & Young as independent auditor passed with 222,343,120 votes for.
  • Advisory Say on Pay proposal passed with 163,104,135 votes for (43,156,553 against).
  • No departures, appointments, or changes to executive compensation were reported.

Financial Impact

2,000,000 new shares authorized for equity grants, representing approximately 0.6% of shares outstanding based on a $12.9B market cap — minimal dilution.

dilution

Risk Factors

  • Say on Pay received 20.9% against votes (43.2M), which is notable but non-binding and below typical threshold for concern.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
58% bullish (26 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000939767-26-000074
Exhibit: exel-20260526.htm0000939767-26-000074
Document: 0000939767-26-000074-index-headers.html0000939767-26-000074
Document: 0000939767-26-000074-index.html0000939767-26-000074
Document: 0000939767-26-000074.txt0000939767-26-000074
10 reports for EXEL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for EXEL — sortable, filterable
Type Now
Jun 3, 2026
6d ago
Insider Cluster
NEUTRAL ★ 2/10
$52.39 $52.69▲ +0.57%▲ +3.17%$51.74 (−1.24%)
May 29, 2026
11d ago
8-K
NEUTRAL ★ 3/10
$50.20 $48.49▼ −3.41%▼ −3.55%$51.74 (+3.07%)
May 28, 2026
12d ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $50.28▼ −0.08%▼ −0.35%$51.74 (+2.83%)
May 28, 2026
12d ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $50.28▼ −0.08%▼ −0.35%$51.74 (+2.83%)
May 28, 2026
12d ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $50.20▼ −0.24%▼ −0.50%$51.74 (+2.83%)
May 22, 2026
18d ago
Insider Cluster
NEUTRAL ★ 3/10
$49.94 $49.82▼ −0.24%▼ −0.25%$51.74 (+3.61%)
May 19, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$49.89 $49.49▼ −0.80%▼ −1.00%$51.74 (+3.71%)
May 7, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$46.10 $48.15▲ +4.45%▲ +3.62%$51.74 (+12.24%)
Apr 17, 2026
7w ago
DEFA14A
NEUTRAL ★ 3/10
$43.59 $45.88▲ +5.25%▲ +5.91%$51.74 (+18.70%)
Feb 28, 2026
14w ago
Institutional Cluster
BULLISH ★ 7/10
$40.98 $40.58▼ −0.98%▼ −0.06%$51.74 (+26.26%)
Showing 10 of 10

US Market Status

Market Closed — Opens in 6h 6m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access